Noven’s Media Center gives you immediate access to current and archived press releases.
Please note that news releases appearing on this website are presented for historical reference, have not been updated for current events, and are current only as of their respective dates of issuance.
- Noven Presents Pre-clinical Study Results At American Association of Pharmaceutical Scientists Annual Meeting - (12/05/00)
- Novartis Builds On Its Leading Presence In Women's Health; State-of-the-art Transdermal Hormone Replacement Therapy Licensed From Noven - (11/06/00)
- Noven Announces Record Financial Results - (11/01/00)
- Noven Appoints Executive Director of Clinical Research/Regulatory Affairs - (10/13/00)
- Sablotsky To Resign As Officer of Noven Strauss And Sablotsky To Serve As Board Co-Chairmen - (9/22/00)
- Noven Announces New Finance Appointments - (9/11/00)
- Noven Announces Vivelle® Approved For Prevention Of Osteoporosis - (8/17/00)
- Noven Announces Record Financial Results - (8/09/00)
- Noven Pharmaceuticals Added To Russell Equity Indexes - (7/12/00)
- Noven Holds Annual Meeting of Shareholders - (6/07/00)
- Noven Announces 2000 First Quarter Financial Results - (5/03/00)
- John G. Clarkson, M.D. Joins Noven Board Of Directors - (4/17/00)
- Noven Completes Successful Phase II Study Of Once-a-day Transdermal Methylphenidate Patch - (3/02/00)
- Noven Announces Record Quarterly And Full-Year Financial Results - (2/24/00)